JPMorgan Buyers of IMAX (IMAX) on Weakness

May 1, 2018 1:16 PM

JPMorgan reiterated an Overweight rating and $28 price target on IMAX Corporation (NYSE: IMAX) following results.The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found